GREENWICH, Conn., July 12, 2017 -- Oxford Lane Capital Corp. (NASDAQ:OXLC) (NASDAQ:OXLCO) (NASDAQ:OXLCN) (NASDAQ:OXLCM) (“OXLC” or the “Company”) announced today that our Board of Directors has declared the dividend for the period June 14, 2017 through July 31, 2017 on our New Series 2024 Term Preferred Shares as follows:
| Per Share Dividend Amount Declared | Record Dates | Payment Dates | |||||||||
| New Series 2024 | $ | 0.22031 | July 17, 2017 | July 31, 2017 | |||||||
About Oxford Lane Capital Corp.
Oxford Lane Capital Corp. is a publicly traded registered closed-end management investment company. Our investment objective is to maximize our portfolio's risk-adjusted total return by purchasing portions of equity and junior debt tranches of collateralized loan obligation ("CLO") vehicles. Structurally, CLO vehicles are entities formed to originate and manage a portfolio of loans. The CLO vehicles which we focus on are collateralized primarily by senior secured loans made to companies whose debt is unrated or is rated below investment grade. Our investment strategy also includes warehouse facilities, which are financing structures intended to aggregate loans that may be used to form the basis of a CLO vehicle.
Forward-Looking Statements
This press release contains forward-looking statements subject to the inherent uncertainties in predicting future results and conditions. Any statements that are not statements of historical fact (including, but not limited to, statements containing the words "believes," "plans," "anticipates," "expects," "estimates" and similar expressions) should also be considered to be forward-looking statements. Certain factors could cause actual results and conditions to differ materially from those projected in these forward-looking statements. These factors are identified from time to time in our filings with the Securities and Exchange Commission. We undertake no obligation to update such statements to reflect subsequent events.
Contact: Bruce Rubin 203-983-5280


Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Apple Turns 50: From Garage Startup to AI Crossroads
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
First Western Ship Transits Strait of Hormuz Since Iran War Began 



